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SA (n= 8) ACS (n = 21) RS (n = 30)
TGF-B1 0.75 i 0.16 1.81 + 0.25” 1.60 + 0.18”
TGF-)2 1.13 * 0,30 2,24 + 0.17*t 1,40 i 0.15
TGF+3 1.63 + 0.26 2.36 + 0.16” 2,27 + 0.13$
TBR-I 2.38 + 0,18 2.36 i 0.16 2.63 * 0.10
T@R-11 2.13 + 0.23 2.05 i 0.19 2.32 + 0.13
Intimalhyperplaaia 36% 71% 90%”
Neovascularization 13”A 57%* 40”/0
“ P <0.05 vs. SA, t P -=0.05 vs. RS
were immunohistochemically analyzed for the expression and localization of
TGF+J (TGF+?l, -fJ2, and +3) and its receptor (TglR-1and -Ii) isoforms ‘in
corona~ plaques (graded from Oto 3).
Immunoreactivity for TGF-A’sand TPRS was observed in the cytoplasm
of smooth muscle cells (a-actin positive), nonfoamy macrophages (CD68
positive) and endothelial cells (CCf31positive). High numbers of TGF-A9and
TBR-positivecells were seen in intimal hyperplasia (IH) and naovascularized
lesions with hemorrhage or inflammation. Moreover, in IH, the expression
level of each TGP-p isoform varied. In conclusion, our results suggeat that
TGF-p isoforms are involved in thepathogenesis of coronaty lesions in acute
coronary syndromes and restenosis, and that they have apacific functions in
the coronary plaque formation.
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D96290 ExerciseInducedChengee of Fibrinolytic endThrombotic Potentiel in Runners Following the
IOOth Boeton Marsthon
J.J. Stec, G.H. T~fler, 1.Lipinska, P.M. Ridker, A.J. Siegel. FfarvardMedica/
School, Boston, MA, USA
Although moderate physical activity ia cardioprotecfive, strenuous exertion
has bean occasionally associated with the triggering of acute myocardial
infarction (AMI). Since thrombosis plays an important pathogenetic role in the
onset of AMI, we examined the effect of marathon running on the fibrinolytic
and thrombotic potential in 24 healthy male participants, mean age 50 + 10
years. The subjects had blood drawn the morning before and within 5 hours
following the IOOthBoston Marathon. Values are mean + standard error of
mean. Paired t-teats were performed.
Befora ‘Aftar o-value
Fibrfnolyticactivity(mmz) 72& 11 173+ 14 0.001
D-Dimer (rig/ml) 180+26 405 &42 0.001
von Willebrsndfsctor (“A) 69 k 9 21O* t4 0.001
C-resctlveprotein (nglml) t47 k35 650+ 110 0.001
Fibrinogen(mg/dl) 2ti* 10 234 * 9 0.03
Marathon running resulted in a significant increase in fibrinolytic activity
and D-Dimer, von Willebrsnd factor and C-reactive protein. Fibrinogen levels
were alightly reduced.
In these healthy participants activation occurred of both fibrinolysis and
prothromhtic factors suggesting a hemostatic balance. Further studies are
needad todetermine theeffecfof prolonged strenuous exerciseonthrombotic
potential, particularly in subjects at increaeed cardiovascular risk.
D96291 Attenuated Success Rate of Thrombolysis forAcute Myocardjal Infarction by Reduced
Endogenous Fibrinolysis
T.K. Nordf, M. Moaer, B. Kohler, K. Peter, C. Bode. Med. Universit#ts/dini/r
Heidelberg, Germany
Resistance to thrombolysis in acute myocardial infarction (AMI) constitutes
a major limitation of this form of therapy. To delineate the contribution of the
various components of the blood coagulation system (i.e. platelet function,
thrombin activity, and endoganous fibrinolytic activity), platelet aggregation
(induced by 2 WMADP), thrombin antithrombin complexes (TAT,measured
by ELlSA), and plasminogen activator inhibitor type-1 (PAI-1,measured both
by ELISA and by using chromogenic substrate S-2251) were determined in
31 patients with AMI at O, 1, and 2 h after initiation of thrombolytic therapy.
Patienta were treatad with fibrin-specific piasminogen activators (t-PA, r-
PA), patency was assessed by coronary angiography at 1.5 h and gradad
according to the TIMI criteria. With respect to platelet aggregation (both slope
and maximum) and TAT levels there was no significant association with the
TIMI grade. TATlevels at Oh even tended to be higher in successfully treated
patients: 2.1 + 0.0 rig/ml with TIMI grade O, 1.6 + 0.2 with [, 5,2 + 2.1
with 11,and 5.0 + 1.3 with Ill (+ SEM). However, plasma concentrations of
PAI-1 were significantly increased in patients with unsuccessful outcome in
comparison to those with successful treatment: 39 * 1 nglml with TIMI grade
0, 31 + 7 with 1,30 + 7 with 11,and 24 + 3 with Ill (+ SEM, p < 0.05). Plasma
activity of PAI-I measured before thrombolysis showed parallel reeults. No
difference could be found for the thrombolytic agent used. Thus, resiatanca
tothrombolyfic therapy in AMI appears to be caused by reduced endogenous
fibrinolysis secondaty to increased PAI-1 in plaama rather than by increaead
platelet orthrombin activity. Patients with elevated baseline PAI-I may profit
more consistently from alternative reperfusion strategies.
962-92 Abnormal Microvascular Responses In Cardiac
Syndrome X Csnnot Be Explained Solely By The
Praeance of Epicardial Subangiographic Atharoma
I.D. Cox, J.R. Clague, J.P. Bagger, D.E. Ward, J.C, Kaski. St. George’s
Hospital, London, UK
Aim.’ To study tha relationship between coronay microvascular rasponses
and epicardial sub-angiographic atheroma (SAA) in syndrome X.
Patients: We studied 9 patients (8 women; median age 55, range 43-72)
with syndrome X (anginal pain, positive exercise ECG and normal coronary
angiogrsphy) who were undergoing repeat corona~ angiography due to
persistent disabling anginai pain despite anti-anginal therapy. None had doc-
umented coronary spasm, blood pressure > 150/95 mmHg, left ventricular
hypertrophy or cholesterol >8.5 mmol/1,and all were non-smokers.
Methods: Vasoactive drugs were stopped ?5 half-lives prior to catheter-
isation, Repeat angiography was completely normal in all caaes. Coronary
flow velocity responses during intracoronary infusion of acefylcholine (ACh
– O, 10-7 and 10-6M) and following an intracoronary bolus of 300 Kg glyc-
eryl trinitrate (GTN) ware assessad uaing a Doppler ultrasound guide-wire
deployad in tha proximal LAD artery. Simultaneous quantitative angiography
was performed to enable calculation of coronary flow volume resewa i.e.
the ratio of baseline to peak flow volume for each dilator (CFR-ACWGTN).
Intimal thickening due to SAA was measured by intravascular ultrasound at
1 mm intervals through tha IAD.
Resu/ts: The median CFR-ACh was 1.78 (range 1.3-4.5) and was clas-
sified as abnormal (< 2) in 5 patients; CFR-GTN was =- 2 in all oaees. Six
patients had significant intimal thickening (> 0.3 mm) and the median mexi-
mal intimal thickness was 1.0 mm (range O-1.2 mm) Two of the five patients
with CFR-ACh <2 had no significant SAA and there was no significant cor-
relation betwaen the saverity of SAA and CFR-ACh (rho = 0.054, p = NS;
Spearman’s Rank Correlation Coefficient).
Cone/usions:Abnormal endothalium-dependent microvascular responses
in syndrome X patients cannot be explained simply by the presence of SAA.
1962-931ThelmpactOfCoronary Flow ReSef’veand,n@in
Resistance on Myocardial Energy Metabolism in
Syndrome X
HE. Batker, H.S. Sonne, J.P. Bagger, T.T.Nielsen. Department nf
Cardiology Skejby University Hospital, Aarhus, Denmark
Itremains controversial whether myocardial ischemia ia preaent in patients
with syndrome X. Myocardial energy efficiency may be compromised due to
an attenuated increment of carbohydrate oxidation during pace strass. To
evaluate the influence of coronary flow reserve and myocardial subatrata up-
taka oncerdiacenergy efficiency,weusadcoronary sinuacatheterization and
studied myocardial metabolism at rest and during pa(e streas in 18 corrsac-
utive patients with syndrome X and in 10 mntrol subject (C). The patiants
were subclassified as microvascular angina (MA, n =8) in the prasence of a
reduced coronary flow reserve (< 2.5) or no microvascular angina (non-MA,
n = 1“0)if coronary flow reserve was presetved (?2.5). Rasu/ts: Patients with
non-MA revealedfasting hyparinsulinemia (55* 5VS.MA: 28*5 and C: 29 +
2pmol x 1-1, p < 0.05) and increased arterial concentration of fraefatlyacids
(FFA) (1,41 + 0,19 vs. MA: 1.22+ 0.15 and C: 1.01 + 0.12 mmol x 1-1, p <
0.05). During pacing, myocerdial uptake of FFAwas increased in the non-MA
patients. Net myocardial lactate release was not observed in any patiants.
In all subjects, myocardial FFA uptake correlated positively while glucose
upfake correlated invarsely with arterial concentrations of FFA. Myocardial
energy expenditure, and net carbohydrate- and lipid oxidation were similar in
the three groups. Conclusion: Not only angina pectoris and ST-segment de-
pression but also a decreased corona~ flow reaerve and insulin resistance,
associated with a relatively increased myocardial FFA uptake, coexist with
presarved myocardial energy efficiency in patients with syndrome X.
